Novartis is a global healthcare company created through the merger of two Swiss companies—Ciba-Geigy and Sandoz. The company operates in three divisions— Innovative Medicines, Alcon (specializes in eye care products), and Sandoz (a leader in the generic medicines industry).
The Sandoz business division is engaged in the development, manufacturing, distribution, and commercialization of prescription medicines as well as pharmaceutical and biotechnological active substances. Sandoz operates globally in the Retail Generics, Anti-infectives, and Biopharmaceuticals & Oncology Injectables segments. It develops, manufactures, and markets active ingredients and finished dosage forms of pharmaceuticals under its Retail Generics segment.